BerGenBio ASA (OSL: BGBIO)

BerGenBio ASA Ratios and Metrics

Market cap in millions NOK. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 21, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	405	747	662	1,794	2,810	1,487
Market Cap Growth	39.89%	12.86%	-63.08%	-36.16%	88.93%	1.81%
Enterprise Value	230	578	437	1,285	2,032	1,198
Last Close Price	10.37	27.80	85.70	232.67	369.43	274.72
PS Ratio	758.49	2111.46	1702.55	2317.66	4675.15	167.10
PB Ratio	2.64	5.86	7.48	4.67	4.19	6.77
P/TBV Ratio	2.58	5.86	7.48	4.67	4.19	6.77
EV/Sales Ratio	374.38	1633.45	1123.96	1660.83	3380.88	134.58
Debt / Equity Ratio	-	0.00	0.00	0.00	0.00	0.00
Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.03
Quick Ratio	4.23	3.55	2.12	6.91	11.04	5.31
Current Ratio	4.71	3.71	2.14	6.92	11.05	5.32
Return on Equity (ROE)	-96.83%	-176.32%	-127.77%	-58.67%	-57.76%	-71.55%
Return on Assets (ROA)	-52.66%	-70.31%	-61.93%	-33.08%	-32.36%	-39.35%
Return on Capital (ROIC)	-64.06%	-110.66%	-80.46%	-37.14%	-36.56%	-45.81%
Earnings Yield	-45.72%	-25.47%	-45.62%	-17.25%	-9.15%	-13.40%
FCF Yield	-35.17%	-30.12%	-43.52%	-16.91%	-8.34%	-12.55%
Buyback Yield / Dilution	-305.85%	-1514.80%	-0.77%	-17.40%	-29.10%	-8.91%
Total Shareholder Return	-305.85%	-1514.80%	-0.77%	-17.40%	-29.10%	-8.91%

Source: S&P Capital IQ. Standard template. Financial Sources.